Background

Tularemia is a highly infectious zoonotic disease caused by Francisella tularensis. Although it is widely distributed across the Northern Hemisphere, its occurrence is uneven and its epidemiology varies considerably by region. The disease is considered endemic in large areas of North America and Eurasia, with particular relevance in Northern and Central Europe, Scandinavia, countries of the former Soviet Union, and Japan. Major outbreaks have also been reported in other countries, reflecting its continuing potential as a public health concern.

 

In humans, infection is not transmitted from person to person and is usually acquired through contact with infected wildlife, ingestion of or contact with contaminated water, bites from ticks and other arthropods, or inhalation of contaminated aerosols. The clinical presentation may vary depending on the route of exposure, infectious dose, and strain virulence, ranging from mild forms to severe infection. In this context, tularemia may be difficult to recognize in its early stages, making the availability of appropriate diagnostic tools especially important, particularly in endemic areas or in patients with a compatible exposure history.

Francisella tularensis

Product features

VIRapid® TULAREMIA is the first commercial immunochromatographic test in the market for the qualitative detection of total antibodies against Francisella tularensis.

  • Visual reading in just 15 minutes.
  • No hazardous diagnosis.
  • All reagents included in the kit.
  • Product control line in each device.
  • Based on LPS (conjugate and test line).
  • Excellent performance: 99% sensitivity and 98% specificity.
kit virapid test rapido

PRODUCTS

VIRAPID® TULAREMIA

CE
Immunochromatographic test for the qualitative, detection of total antibodies against Francisella tularensis in serum/plasma samples. 10 tests.

Analytes: Francisella tularensis

Reference VR006
Pack size 10 tests

MORE RESOURCES

Virus/Bacterias
RELATED VIRUSES/BACTERIA

Related germs and organisms categorized for this product line.

Flyers
FLYERS

Downloadable PDF materials, brochures, and technical documents.

Blog
BLOG

The latest insights, news, and research articles from our scientific team.

Infecciones vaginales polimicrobianas: por qué importan los controles de terceros en diagnóstico molecular
02 July 2026

Infecciones vaginales polimicrobianas: por qué importan los controles de terceros en diagnóstico molecular

Understanding the complexity of vaginal infectionsVaginal infections are among the most frequent reasons for gynecological consultation, but their dia...

Beyond detection: H. pylori testing in today’s laboratory workflow
26 June 2026

Beyond detection: H. pylori testing in today’s laboratory workflow

Helicobacter pylori remains a highly relevant target in gastrointestinal diagnostics. It is a familiar pathogen, but its clinical importance has not d...

Aspergillus galactomannan: a practical biomarker for invasive aspergillosis diagnosis
15 May 2026

Aspergillus galactomannan: a practical biomarker for invasive aspergillosis diagnosis

Invasive aspergillosis is still one of the most difficult fungal infections to diagnose early. It mainly affects patients with weakened immune systems...

Bibliography
BIBLIOGRAPHY

Scientific bibliography and references related to this product.

Chaignat V, Djordjevic-Spasic M, Ruettger A, Otto P, Klimpel D, Müller W, et al. Performance of seven serological assays for diagnosing tularemia. BMC Infect Dis. 2014;14:234. PMID:24885274; PMCID:PMC4021340.
Kiliç S, Çelebi B, Yeşilyurt M. Evaluation of a commercial immunochromatographic assay for the serologic diagnosis of tularemia. Diagnostic Microbiology and Infectious Disease. 2012 Sep;74(1):1–5.
Plymoth M, Lundqvist R, Nystedt A, Sjöstedt A, Gustafsson TN. Targeting Tularemia: Clinical, Laboratory, and Treatment Outcomes From an 11-year Retrospective Observational Cohort in Northern Sweden. Clinical Infectious Diseases. 2024 May 15;78(5):1222–31.